Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
The British Journal of Dermatology
|
August 14, 2012
Getting in early: primary skin cancer prevention at 55 German kindergartens
L A Stöver, B Hinrichs, U Petzold, et al.
Anti-Cancer Drugs
|
October 1, 1995
Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell lines
A Harstrick, U Vanhoefer, N Schleucher, et al.
International Journal of Cancer
|
March 5, 2019
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
Tatsuo Sugawara, Simon J Baumgart, Ekaterina Nevedomskaya, et al.
Cancer Chemotherapy and Pharmacology
|
July 8, 1998
Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors
R A Hilger, A Harstrick, W Eberhardt, et al.
Climacteric : the Journal of the International Menopause Society
|
May 8, 2013
Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patients
J Baumgart, K Nilsson, A Stavreus Evers, et al.
Cells
|
May 28, 2022
Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CAD
Julian C Bachmann, Simon J Baumgart, Anna K Uryga, et al.
Nucleic Acids Research
|
May 6, 2017
CHD1 regulates cell fate determination by activation of differentiation-induced genes
Simon J Baumgart, Zeynab Najafova, Tareq Hossan, et al.
Biophysical Chemistry
|
April 1, 1990
Physiochemical characterization of substituted chromeno[4,3-b][1,5]benzodiazepine stereoisomers designed as cell membrane active antitumor agents
W Werner, J Baumgart, G Burckhardt, et al.
Drug Intelligence & Clinical Pharmacy
|
July 1, 1988
Evaluation of therapeutic drug monitoring in a long-term care facility: a pilot project
F Pucino, P J Baumgart, G L Strommen, et al.
Acta Histochemica
|
January 1, 1992
Fluorenone-azomethines, a novel class of microtubule inhibitors that specifically affect cell proliferation
B Oertel, W Vater, E M Wiederhold, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
The British Journal of Dermatology
|
August 14, 2012
Getting in early: primary skin cancer prevention at 55 German kindergartens
L A Stöver, B Hinrichs, U Petzold, et al.
Anti-Cancer Drugs
|
October 1, 1995
Activity of N-benzyl-adriamycin-14-valerate (AD198), a new anthracycline derivate, in multidrug resistant human ovarian and breast carcinoma cell lines
A Harstrick, U Vanhoefer, N Schleucher, et al.
International Journal of Cancer
|
March 5, 2019
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
Tatsuo Sugawara, Simon J Baumgart, Ekaterina Nevedomskaya, et al.
Cancer Chemotherapy and Pharmacology
|
July 8, 1998
Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors
R A Hilger, A Harstrick, W Eberhardt, et al.
Climacteric : the Journal of the International Menopause Society
|
May 8, 2013
Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patients
J Baumgart, K Nilsson, A Stavreus Evers, et al.
Cells
|
May 28, 2022
Fibrotic Signaling in Cardiac Fibroblasts and Vascular Smooth Muscle Cells: The Dual Roles of Fibrosis in HFpEF and CAD
Julian C Bachmann, Simon J Baumgart, Anna K Uryga, et al.
Nucleic Acids Research
|
May 6, 2017
CHD1 regulates cell fate determination by activation of differentiation-induced genes
Simon J Baumgart, Zeynab Najafova, Tareq Hossan, et al.
Biophysical Chemistry
|
April 1, 1990
Physiochemical characterization of substituted chromeno[4,3-b][1,5]benzodiazepine stereoisomers designed as cell membrane active antitumor agents
W Werner, J Baumgart, G Burckhardt, et al.
Drug Intelligence & Clinical Pharmacy
|
July 1, 1988
Evaluation of therapeutic drug monitoring in a long-term care facility: a pilot project
F Pucino, P J Baumgart, G L Strommen, et al.
Acta Histochemica
|
January 1, 1992
Fluorenone-azomethines, a novel class of microtubule inhibitors that specifically affect cell proliferation
B Oertel, W Vater, E M Wiederhold, et al.
Page
of 7